Filing Details

Accession Number:
0001209191-23-035613
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-08 21:12:06
Reporting Period:
2023-06-06
Accepted Time:
2023-06-08 21:12:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534133 Calcimedica Inc. CALC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1267959 A Fred Middleton C/O Calcimedica, Inc.
505 Coast S. Blvd. #202
La Jolla CA 92037
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-06 500 $4.88 10,500 No 4 P Direct
Common Stock Acquisiton 2023-06-07 500 $5.20 11,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 703,388 Indirect By Sanderling Venture Partners VI, L.P.
Common Stock 582,757 Indirect By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock 17,682 Indirect By Sanderling Ventures Management VI
Common Stock 7,456 Indirect By Sanderling VI Beteligungs GmbH & Co KG
Common Stock 8,884 Indirect By Sanderling VI Limited Partnership
Common Stock 240,676 Indirect By Sanderling Ventures VII, L.P.
Common Stock 14,425 Indirect By Sanderling Ventures VII Annex Fund, L.P.
Common Stock 63,228 Indirect By Sanderling Ventures VII (Canada), L.P.
Common Stock 1,548 Indirect By Sanderling Ventures Management VII
Common Stock 8,176 Indirect By Golden Triangle Ventures, LLC
Footnotes
  1. The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI, LP, Sanderling Venture Partners VI Co-Investment Fund, LP, Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (together, the "Sanderling VI Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VI Securities except to the extent of his pecuniary interest therein.
  2. The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Ventures VII, LP, Sanderling Ventures Management VII, Sanderling Ventures VII (Canada), LP and Sanderling Ventures VII Annex Fund, L.P. (together, the "Sanderling VII Securities"). The Reporting Person disclaims beneficial ownership of the Sanderling VII Securities except to the extent of his pecuniary interest therein.
  3. The Reporting Person is a managing member of Golden Triangle Ventures LLC and may be deemed to beneficially own the securities of the Issuer held by Golden Triangle Ventures LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.